IMC Chicago
RXRX icon

IMC Chicago’s Recursion Pharmaceuticals RXRX Stock Holding History

IMC Chicago’s Portfolio RXRX Stock Details RXRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$473K Buy
+114,576
New +$388K ﹤0.01% 4754
2025
Q4 		– Sell
-66,215
Closed -$328K – 4380
2025
Q3 		$323K Buy
+66,215
New +$348K ﹤0.01% 3383
2025
Q2 		– Sell
-183,040
Closed -$899K – 3551
2025
Q1 		$968K Buy
+183,040
New +$1.33M ﹤0.01% 2291

Other funds holding RXRX

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $106B AUM 2.29% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $174B AUM 33.96% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $420B AUM 34.97% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Creative Planning
Creative Planning Overland Park, Kansas $179B AUM 16.96% 1-Year Est. Return
RhumbLine Advisers
RhumbLine Advisers Boston, Massachusetts $134B AUM 35.21% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return

IMC Chicago's RXRX Position: Q3 2026 in Review

IMC Chicago opened a new position in Recursion Pharmaceuticals (RXRX) in Q3 2026: 114,576 shares worth $473K. The stake represents ﹤0.01% of the portfolio and ranks #4754 among its holdings. This is a return to the name: IMC Chicago previously reported a position in RXRX as recently as Q3 2025.

IMC Chicago first reported a position in RXRX in Q1 2025 and has held it in 3 quarters since. The position peaked at $968K in Q1 2025. 178 funds tracked by Wall St. Rank hold RXRX as of Q3 2026.

  • IMC Chicago held 114,576 shares of Recursion Pharmaceuticals worth $473K as of Q3 2026.
  • Recursion Pharmaceuticals was a new IMC Chicago position in Q3 2026.
  • Recursion Pharmaceuticals made up ﹤0.01% of IMC Chicago's portfolio in Q3 2026, its #4754 holding.
  • IMC Chicago first reported a position in Recursion Pharmaceuticals in Q1 2025 and has held it in 3 quarters since.
  • IMC Chicago's Recursion Pharmaceuticals position peaked at $968K in Q1 2025.
  • 178 funds tracked by Wall St. Rank held Recursion Pharmaceuticals as of Q3 2026.

Based on IMC Chicago's 13F filing for Q3 2026, filed 5 Nov 2026.